Bilkent City Hospital — Ankara, Ankara

Public research footprint of Bilkent City Hospital, compiled from the ClinicalTrials.gov public registry.

305

Registered studies

126

Active

Recruiting now

158

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Advanced or Metastatic Non-small Cell Lung Cancer · Neovascular Age-related Macular Degeneration (nAMD) · Arthritis, Psoriatic

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT06741969 — Nipocalimab in Moderate to Severe Sjogren's Disease (Active Not Recruiting)
NCT04929210 — A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Bilkent City Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.